Drug-eluting stents studies in mice: do we need atherosclerosis to study restenosis?

Vascular Pharmacology
Nuno M M PiresPaul H A Quax

Abstract

In 2001, the first human study with drug-eluting stents (DES) was published showing a nearly complete abolition of restenosis by using a sirolimus-eluting stent. This success was very encouraging to test new compounds in combination with the DES platform. Nevertheless, several other anti-restenotic compounds have been used in human clinical trials with disappointing outcomes. Little is known concerning potential adverse effects on vessel wall integrity and (re)healing, atherosclerotic lesion formation, progression, and plaque stability of these DES. Although efficacy and safety need to be determined clinically, preclinical testing of candidate drugs in well-defined animal models is extremely helpful to gain insight into the basic biological responses to candidate compounds. Here, we discuss and report an animal model which enables rapid screening of candidate drugs for DES on an atherosclerotic background. The results from drug testing using this novel model could help to quickly and cost-effectively establish the dose range of candidate drugs with reasonable potential for DES.

References

Jul 28, 1968·Journal of Molecular Biology·W Müller, D M Crothers
Apr 13, 1995·The New England Journal of Medicine·E K Rowinsky, R C Donehower
Jan 1, 1994·Pharmacotherapy·D R Kohler, B R Goldspiel
Aug 1, 1994·Current Opinion in Lipidology·B PaigenE M Rubin
Apr 7, 1994·The New England Journal of Medicine·C LandauL D Hillis
Nov 1, 1993·Circulation Research·V LindnerM A Reidy
May 3, 1996·Science·J L Breslow
Oct 9, 1998·Cardiovascular Research·P CarmelietD Collen
Jun 29, 1999·The Journal of Surgical Research·T D ReilH A Gelabert
Apr 29, 2000·Circulation Research·C J CreelE R Edelman
Dec 29, 2000·Journal of the American College of Cardiology·D E DrachmanC Rogers
Jun 7, 2002·The New England Journal of Medicine·Marie-Claude MoriceUNKNOWN RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patie
Oct 3, 2002·Circulation·Robert S SchwartzUNKNOWN Consensus Committee
Oct 31, 2002·Circulation·Andrew FarbRenu Virmani
Apr 18, 2003·The New England Journal of Medicine·Seung-Jung ParkGary S Mintz
Oct 1, 2003·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Xiaoshun LiuIvan De Scheerder
Oct 3, 2003·The New England Journal of Medicine·Jeffrey W MosesUNKNOWN SIRIUS Investigators
Oct 23, 2003·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Heinrich WienekeRaimund Erbel
Jul 13, 2004·The American Journal of Cardiology·Rainer HoffmannPeter Hanrath
Sep 4, 2004·Coronary Artery Disease·Renu VirmaniFrank D Kolodgie
Feb 22, 2005·International Journal of Cardiology·Barend L van der HoevenJ Wouter Jukema

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.